[go: up one dir, main page]

Yoneda et al., 1985 - Google Patents

Control of VX2 carcinoma cell growth in culture by calcium, calmodulin, and prostaglandins

Yoneda et al., 1985

View PDF
Document ID
9178247478047842431
Author
Yoneda T
Kitamura M
Ogawa T
Aya S
Sakuda M
Publication year
Publication venue
Cancer research

External Links

Snippet

Based on our in vivo observation that growth of VX2 carcinoma transplanted in rabbits paralleled development of hypercalcemia, we studied the regulation of VX2 tumor growth using a clonal cell line isolated from VX2 tumor (VX2-L). VX2-L cell growth was dependent …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Baker et al. Dexamethasone modulates binding and action of epidermal growth factor in serum-free cell culture
Proper et al. Mouse embryos contain polypeptide growth factor (s) capable of inducing a reversible neoplastic phenotype in nontransformed cells in culture
Partridge et al. Receptors for 1, 25 (OH) 2-vitamin D3 enriched in cloned osteoblast-like rat osteogenic sarcoma cells
Yoneda et al. Control of VX2 carcinoma cell growth in culture by calcium, calmodulin, and prostaglandins
Ossowski et al. Mammary plasminogen activator: correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue
VIGNON et al. Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein
LEVESTON et al. Acromegaly and Cushing's syndrome associated with a foregut carcinoid tumor
Granchi et al. Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells
Kanematsu et al. Effect of insulin-like growth factor 1 on gonadotropin release from the hypothalamus-pituitary axis in vitro
Orth FSH-induced Sertoli cell proliferation in the developing rat is modified by β-endorphin produced in the testis.
Yashiro et al. Expression of insulin-like growth factor receptors in primary human thyroid neoplasms
HINKLE et al. Mechanism of thyroid hormone inhibition of thyrotropin-releasing hormone action
Jimenez-Krassel et al. Evidence for a negative intrafollicular role for inhibin in regulation of estradiol production by granulosa cells
Masters et al. Insulin receptors and insulin action in dissociated brain cells
JP2021512874A (en) A pharmaceutical composition for the prevention or treatment of rheumatoid arthritis containing isolated mitochondria
Enomoto et al. Establishment of a human undifferentiated thyroid cancer cell line producing several growth factors and cytokines
Sato et al. Expression of epidermal growth factor and transforming growth factor-β in a human salivary gland adenocarcinoma cell line
US7964400B2 (en) Immune potentiating compositions of cancer cells
Tabibzadeh et al. Human endometrial epithelial cell lines for studying steroid and cytokine actions
Hassid Modulation of cyclic 3′ 5′‐adenosine monophosphate in cultured renal (MDCK) cells by endogenous prostaglandins
Ichikawa et al. Progression and selection in heterogeneous tumor composed of androgen-responsive Shionogi Carcinoma 115 and its autonomous subline (Chiba Subline 2)
Errick et al. Epidermal growth factor inhibits thyrotropin-mediated synthesis of tissue-specific proteins in cultured ovine thyroid cells
Smith Functional differentiation of virgin mouse mammary epithelium in explant culture is dependent upon extracellular proline
Levy et al. Rat epiphyseal cells in culture: responsiveness to bone-seeking hormones
Hamburger et al. Monocyte-derived growth factors for human tumor clonogenic cells